Product information

Current status:

Cancelled Pre Market

Current status date:

2021-07-30

Original market date: ^{See footnote 1}

Product name:

THROMBOGEN

DIN:

02231137 Electronic product monograph is not available

Company:

JOHNSON & JOHNSON MEDTECH, A DIVISION OF JOHNSON & JOHNSON (CANADA) INC.
200 Whitehall Drive
Markham
Ontario
Canada L3R 0T5

Class:

Human

Dosage form(s):

Powder

Route(s) of administration:

Topical

Number of active ingredient(s):

1

Schedule(s):

Schedule D

American Hospital Formulary Service (AHFS): ^{See footnote 3}

20:28.16 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B02BC06 THROMBIN

Active ingredient group (AIG) number:^{See footnote5}

0132987001